Quantum-Si (NASDAQ:QSI) CFO Sells $11,042.56 in Stock

Key Points

  • CFO Jeffry Keyes sold 8,627 shares at an average price of $1.28 for $11,042.56, trimming his holding by ~0.74% to 1,163,197 shares (worth ~ $1.49M).
  • Multiple insiders also sold the same day — CEO Jeffrey Hawkins (~23,707 shares) and director John Vieceli (~21,927 shares) — a pattern that amplifies the negative insider‑selling signal.
  • Quantum‑Si remains unprofitable with only $0.55M revenue in the latest quarter and extreme negative margins, while Canaccord cut its price target to $1.50 (hold); the company has a market cap of ~$273.7M and a 52‑week range of $0.95–$5.77.

Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) CFO Jeffry Keyes sold 8,627 shares of the stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $1.28, for a total value of $11,042.56. Following the completion of the transaction, the chief financial officer directly owned 1,163,197 shares in the company, valued at approximately $1,488,892.16. This represents a 0.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Quantum-Si Price Performance

Quantum-Si stock opened at $1.27 on Tuesday. The business has a 50-day simple moving average of $1.66 and a two-hundred day simple moving average of $1.58. The company has a market cap of $273.67 million, a P/E ratio of -1.90 and a beta of 2.97. Quantum-Si Incorporated has a 52-week low of $0.95 and a 52-week high of $5.77.

Quantum-Si (NASDAQ:QSI - Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported ($0.17) earnings per share for the quarter, hitting the consensus estimate of ($0.17). The firm had revenue of $0.55 million for the quarter, compared to analysts' expectations of $0.60 million. Quantum-Si had a negative net margin of 3,677.97% and a negative return on equity of 47.90%. Research analysts anticipate that Quantum-Si Incorporated will post -0.65 EPS for the current fiscal year.

Hedge Funds Weigh In On Quantum-Si




Large investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in shares of Quantum-Si by 0.5% in the third quarter. Vanguard Group Inc. now owns 8,714,507 shares of the company's stock worth $12,287,000 after acquiring an additional 44,846 shares during the period. Millennium Management LLC bought a new position in Quantum-Si in the 1st quarter worth approximately $4,721,000. Geode Capital Management LLC boosted its stake in Quantum-Si by 15.1% in the 2nd quarter. Geode Capital Management LLC now owns 3,447,738 shares of the company's stock worth $6,759,000 after purchasing an additional 452,850 shares during the period. Squarepoint Ops LLC bought a new stake in shares of Quantum-Si during the third quarter valued at approximately $865,000. Finally, Bank of America Corp DE lifted its holdings in shares of Quantum-Si by 426.6% in the second quarter. Bank of America Corp DE now owns 465,999 shares of the company's stock worth $913,000 after buying an additional 377,504 shares in the last quarter. 39.90% of the stock is currently owned by hedge funds and other institutional investors.

More Quantum-Si News

Here are the key news stories impacting Quantum-Si this week:

  • Positive Sentiment: Launched Version 3 library‑preparation kit and a suite of data‑analysis enhancements — a commercial / product execution update that may help drive sample kit revenue, customer adoption and show progress against commercialization targets. Quantum‑Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements
  • Neutral Sentiment: Canaccord cut its price target from $2.00 to $1.50 and moved to a "hold" rating — the new PT still implies upside vs. current levels but reflects reduced near‑term expectations; this is a near‑term sentiment headwind from an institutional analyst. Quantum‑Si price target lowered to $1.50 from $2 at Canaccord
  • Negative Sentiment: CEO Jeffrey Hawkins sold 23,707 shares at ~$1.28 (≈$30.3k), reducing his stake ~0.91% — insider selling can be viewed negatively by investors even if proceeds are modest. SEC filing — CEO sale
  • Negative Sentiment: CFO Jeffry Keyes sold 8,627 shares at ~$1.28 (≈$11.0k), a ~0.74% reduction in his holding — additional insider sales this session add to selling signal. SEC filing — CFO sale
  • Negative Sentiment: Director/insider John Vieceli sold 21,927 shares at ~$1.28 (≈$28.1k), trimming his stake by ~2.66% — multiple insiders selling the same day amplifies concern over near‑term insider conviction. SEC filing — Insider sale

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Canaccord Genuity Group decreased their target price on Quantum-Si from $2.00 to $1.50 and set a "hold" rating on the stock in a report on Monday. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Quantum-Si in a research report on Monday, December 8th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $3.60.

View Our Latest Stock Report on Quantum-Si

Quantum-Si Company Profile

(Get Free Report)

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.

Further Reading

Insider Buying and Selling by Quarter for Quantum-Si (NASDAQ:QSI)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Quantum-Si?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Quantum-Si and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles